Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M70,904Revenue (TTM) $M17,093Net Margin (%)83.9Altman Z-Score1.3
Enterprise Value $M81,216EPS (TTM) $35.4Operating Margin %-8.0Piotroski F-Score7
P/E(ttm)5.4Beneish M-Score-1.9Pre-tax Margin (%)-14.6Higher ROA y-yY
Price/Book0.910-y EBITDA Growth Rate %--Quick Ratio3.9Cash flow > EarningsN
Price/Sales4.25-y EBITDA Growth Rate %-8.2Current Ratio4.0Lower Leverage y-yY
Price/Free Cash Flow27.3y-y EBITDA Growth Rate %286ROA % (ttm)10.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)17.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M375ROIC % (ttm)-0.8Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNCarl Icahn 2016-09-30 Reduce-3.39%$230.31 - $260.24
($244.37)
$ 190.37-22%Reduce -87.49%425,438
AGNLeon Cooperman 2016-09-30 Reduce-0.85%$230.31 - $260.24
($244.37)
$ 190.37-22%Reduce -19.38%541,122
AGNDavid Tepper 2016-09-30 Reduce-0.26%$230.31 - $260.24
($244.37)
$ 190.37-22%Reduce -3.37%1,218,309
AGNJohn Paulson 2016-09-30 Reduce-0.14%$230.31 - $260.24
($244.37)
$ 190.37-22%Reduce -1.45%3,891,134
AGNWallace Weitz 2016-09-30 Add0.12%$230.31 - $260.24
($244.37)
$ 190.37-22%Add 2.35%609,963
AGNPrivate Capital 2016-09-30 Reduce-0.09%$230.31 - $260.24
($244.37)
$ 190.37-22%Reduce -1.93%134,667
AGNVanguard Health Care Fund 2016-09-30 Reduce-0.07%$230.31 - $260.24
($244.37)
$ 190.37-22%Reduce -1.23%11,917,739
AGNJoel Greenblatt 2016-09-30 Sold Out -0.06%$230.31 - $260.24
($244.37)
$ 190.37-22%Sold Out0
AGNMario Gabelli 2016-09-30 Reduce-0.01%$230.31 - $260.24
($244.37)
$ 190.37-22%Reduce -8.09%55,988
AGNTom Gayner 2016-09-30 Buy 0.01%$230.31 - $260.24
($244.37)
$ 190.37-22%New holding2,000
AGNRuane Cunniff 2016-09-30 Reduce$230.31 - $260.24
($244.37)
$ 190.37-22%Reduce -10.48%3,075
AGNKen Fisher 2016-09-30 Add$230.31 - $260.24
($244.37)
$ 190.37-22%Add 11.96%4,024
AGNRon Baron 2016-09-30 Add$230.31 - $260.24
($244.37)
$ 190.37-22%Add 22.88%17,109
AGNDavid Tepper 2016-06-30 Add5.96%$201.65 - $277.55
($231.14)
$ 190.37-18%Add 351.73%1,260,809
AGNCarl Icahn 2016-06-30 Buy 3.88%$201.65 - $277.55
($231.14)
$ 190.37-18%New holding3,400,000
AGNJohn Paulson 2016-06-30 Reduce-2.98%$201.65 - $277.55
($231.14)
$ 190.37-18%Reduce -27.13%3,948,451
AGNWallace Weitz 2016-06-30 Add2.53%$201.65 - $277.55
($231.14)
$ 190.37-18%Add 95.58%595,961
AGNSteve Mandel 2016-06-30 Sold Out -2.39%$201.65 - $277.55
($231.14)
$ 190.37-18%Sold Out0
AGNRuane Cunniff 2016-06-30 Reduce-2.13%$201.65 - $277.55
($231.14)
$ 190.37-18%Reduce -99.67%3,435
AGNDavid Einhorn 2016-06-30 Sold Out -1.99%$201.65 - $277.55
($231.14)
$ 190.37-18%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SAUNDERS BRENT LCEO and President 2016-11-21Buy5,250$189.130.3view
Hilado Maria TeresaCFO 2016-11-11Buy1,422$210.64-9.95view
Basgoz NesliDirector 2016-08-05Sell758$253.02-25.03view
Hilado Maria TeresaCFO 2016-06-02Buy661$241.57-21.48view
Basgoz NesliDirector 2016-05-11Sell459$225.1-15.73view
Basgoz NesliDirector 2015-12-07Sell2,300$312.96-39.39view
BISARO PAULExec Chairman 2015-08-24Buy1,000$297.42-36.22view
SAUNDERS BRENT LCEO and President 2015-08-21Buy1,000$301.94-37.18view
Basgoz NesliDirector 2015-06-09Sell2,200$297.89-36.32view
Meury WilliamSee Remarks 2014-11-26Sell4,550$269.14-29.52view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

News about AGN:

Articles On GuruFocus.com
Teva Is a Hold Nov 30 2016 
Weekly CEO Buys Highlight Nov 29 2016 
Weekly Top Insider Buys Highlight for Week of Nov. 18 Nov 19 2016 
John Griffin Expands Portfolio in 3rd Quarter Nov 16 2016 
Weitz Funds Comments on Allergan Nov 11 2016 
Weitz Balanced Fund 3rd Quarter Commentary Nov 11 2016 
3 Health Industry Sectors Bound to Profit From a Trump Presidency Nov 11 2016 
Markel’s Tom Gayner Buys 4 Stocks During Quarter Nov 08 2016 
Buy Health Care Now? It All Depends on the Election Nov 07 2016 
Allergan: Trading at a Low Earnings Multiple Nov 06 2016 

More From Other Websites
5 Healthcare Stocks Billionaires Love The Most Dec 04 2016
7:01 am Allergan announces that they, along with Qualicaps have reached a settlement regarding their... Dec 04 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in... Dec 02 2016
Shire Loses Ground To Allergan In Thanksgiving Week Dry-Eye Scripts Dec 02 2016
Oaktree Reduces, Eliminates Multiple Positions in the 3rd Quarter Dec 02 2016
Billionaire Investors Are Bullish On These 5 Stocks Dec 02 2016
Allergan & Amgen Looking for Approvals (AGN, AMGN) Dec 02 2016
Amgen, Allergan apply for European nod for Avastin biosimilar Dec 02 2016
Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines... Dec 02 2016
Stock Futures Hold Lower After U.S. Adds 178,000 Jobs Dec 02 2016
Allergan Provides Update on Accelerated Share Repurchase (ASR) Program Dec 02 2016
Allergan settles patent litigation with Zydus Pharma and Cadila regarding ulcerative colitis... Dec 02 2016
Allergan Announces Settlement of a DELZICOL® (mesalamine) Patent Litigation Dec 02 2016
Pharma execs weigh in on possible changes under Trump Dec 01 2016
Allergan CEO: We're in era of populism & drug industry is... Dec 01 2016
Allergan CEO expects drug industry to face pricing heat from Trump Dec 01 2016
The Deal Economy Event Is Live Dec 01 2016
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Dec 01 2016
Allergan CEO: 'I worry today that pharma has a false sense of relief or security' with Trump... Dec 01 2016
Valeant-Takeda Salix Negotiations Bust On $10 Billion Price: Report Nov 30 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)